Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An international panel of experts led by NDORMS researchers has developed a reporting guideline which supports the reporting quality of patent landscapes, ultimately promoting better informed decision-making in technology development and research direction.

Hands type on a laptop keyboard. Overlaid over the image is an icon of a lightbulb in white.

Patent landscapes are overviews of the patenting activity in a particular field of technology, locally or globally, and provide unique and valuable insights to government, industry or research leaders.

They help key stakeholders identify new areas for research and development and are used to inform policy discussions, strategic research planning and technology transfer.

With patent landscapes often forming the basis of future research agendas in any given field, and informing next steps in technological investment, it is critical we deliver excellent quality patent landscape articles and reports.

The reporting checklist “Reporting Items for Patent Landscapes” (RIPL), published in Nature Biotechnology, offers a framework for articles published in academic journals through a consensus-based set of minimum criteria to include in patent landscape articles. Not only does RIPL provide straightforward and robust support for authors and editors, but its take-up also aids reproducibility and evidence synthesis.

“We want to improve the reporting of patent landscapes to ensure their societal impact is as significant as it can be. The reporting guidelines we have developed aim to do just that by providing support for authors, reviewers and editors working on patent landscape articles.” says Professor Andrew Carr.

Many patent landscapes are now gaining widespread attention through publication in high-impact journals, but unfortunately recent research showed their reporting to be inadequate.

Professor Carr adds: “In addition to authors and editors using RIPL, journal endorsement of the guidelines would encourage adherence and provide a uniform set of requirements for authors publishing in the field. We hope journals are watching this space.”

Reporting guidelines are commonly used in publications of health and biomedical research, where they have shown to improve reporting quality and ultimately lead to better, more transparent research with greater potential for impact.

The guideline has been registered with the EQUATOR Network, an international initiative that seeks to improve the reliability and value of published health research literature by promoting transparent and accurate reporting and wider use of robust reporting guidelines.

Read the full paper

The Reporting Items for Patent Landscapes statement

Nature Biotechnology volume36pages10431047 (2018)

Similar stories

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.